Culturelle® with Lactobacillus rhamnosus GG (LGG®) for children

Digestive and immune support from the #1 pediatrician-recommended probiotic†

Balance intestinal microbiota, assist digestion and support kids’ immune systems with Culturelle®

Due to factors such as antibiotics and diet, the microbiota of children may be out of balance, leaving them more vulnerable to infections or gastrointestinal issues.1 This is especially concerning, considering that kids are exposed to a variety of pathogens in daycare2 and up to 30% of them suffer from issues of regularity.3

Extensive study has found LGG®, the probiotic in Culturelle®, to help balance intestinal microbiota, demonstrating a host of immune support and gastrointestinal benefits including acute diarrhea, antibiotic-associated diarrhea (AAD), and C. difficile induced colitis.4-9

Interested in additional clinical research and data for LGG® supplementation Learn more

LGG® highly recommended across medical community

LGG supplementation is recommended by the European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) and the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) recommends LGG® supplementation for the prevention of:5-9

  • Antibiotic-associated diarrhea
  • Nosocomial diarrhea
  • Acute gastroenteritis

The Culturelle Advantage

When compared to other probiotics, Culturelle® has undergone significantly more clinical study, is more tailored for the unique needs of children, and is less expensive for your patients.

{CMS alt text}

Culturelle® offers products to support children’s immune systems and to restore regularity

For day-to-day digestive support, Culturelle® offers a line of products dedicated to children. All products feature LGG®, the #1 clinically studied probiotic strain.*††

Explore our wide range of products and learn why Culturelle® is the #1 pediatrician recommended brand of probiotics. Learn more

  • Langdon A, Crook N, Dantas G. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Medicine. 2016;8(39):1-16.
  • Centers for Disease Control and Prevention. Infectious diseases in childcare setting. Accessed August 28, 2017.
  • Mugie SM, Benninga MA, Di Lorenzo C. Epidemiology of constipation in children and adults: A systematic review. Best Pract Res Clin Gastroenterol. 2011;25(1):3-18.
  • Goldin BR, Gorbach SL. Clinical indications for probiotics: An overview. Clin Infect Dis. 2008;46 Suppl 2:S96-100; discussion S144-51.
  • Szajewska H, Canani RB, Guarino A.Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children. JPGN. 2016; 62(3):495-506.
  • Guarino A,Ashkenazi S, Gendrel D, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: Update 2014. JPGN.2014;59:132–152.
  • Hojsak I, Szajewska H, Canani RB, et al. Probiotics for the prevention of nosocomial diarrhea in children. JPGN. 2017. Published online. doi: 10.1097/MPG.0000000000001637.
  • Vanderhoof JA, Whitney DB, Antonson DL, et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children.J Pediatr. 1999;135:564-568.
  • Guandalini S, Pensabene L, Zikri MA, et al: Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr. 2000 30(1):54–60.